[{"type": "title", "data": "ID Cellulitis Skin and Soft Tissue Infection (SSTI) (Version 1.79)"}, {"type": "category", "data": "Patient Care"}, {"type": "note", "data": "For diabetic foot infection and necrotizing fasciitis, refer to condition-specific powerplans and consult infectious disease specialist. "}, {"type": "order", "data": "Wound Care", "value": ""}, {"type": "sentence", "data": "Nursing to determine the most appropriate dressings for wound management as per best practice guidelines"}, {"type": "sentence", "data": "Dressing Change, Daily, Nursing to determine the most appropriate dressings for wound management as per best practice guidelines"}, {"type": "sentence", "data": "Dressing Change, BID, Nursing to determine the most appropriate dressings for wound management as per best practice guidelines"}, {"type": "order", "data": "Wound Care", "value": ""}, {"type": "sentence", "data": "Dressing Change, as per Nurse Specialized in Wound, Ostomy and Continence (NSWOC) directions"}, {"type": "order", "data": "Communication Order", "value": ""}, {"type": "sentence", "data": "Do not outline area of redness"}, {"type": "category", "data": "Activity"}, {"type": "order", "data": "Elevate Extremity", "value": ""}, {"type": "order", "data": "Activity as Tolerated (AAT)", "value": ""}, {"type": "order", "data": "Weight Bearing as Tolerated (WBAT)", "value": ""}, {"type": "order", "data": "Non Weight Bearing", "value": ""}, {"type": "category", "data": "Medications"}, {"type": "note", "data": "Do not outline area of redness (not a reliable indicator of response). Increased redness/extension of cellulitis may occur after initiation of antibiotic therapy (due to bacterial toxin release); assess response to initial therapy after 3 days "}, {"type": "note", "data": "Skin discolouration and swelling may take longer to resolve"}, {"type": "note", "data": "Non-Purulent Cellulitis/Erysipelas "}, {"type": "note", "data": "<SPAN lang=EN><P dir=ltr align=left>Mild/Moderate</P></SPAN>"}, {"type": "note", "data": "<FONT style=&quot;BACKGROUND-COLOR: #ffff80&quot;>Select cephalexin OR amoxicillin</FONT>"}, {"type": "order", "data": "cephalexin", "value": ""}, {"type": "sentence", "data": "500 mg, PO, Tab, QID, 5 day(s)"}, {"type": "sentence", "data": "1,000 mg, PO, Tab, QID, 5 day(s)"}, {"type": "order", "data": "amoxicillin", "value": ""}, {"type": "sentence", "data": "500 mg, PO, Cap, TID, 5 day(s)"}, {"type": "sentence", "data": "1,000 mg, PO, Tab, TID, 5 day(s)"}, {"type": "note", "data": "<FONT style=&quot;BACKGROUND-COLOR: #ffff80&quot;>For cephalopsorin allergy, consult Infection Disease Specialist</FONT>"}, {"type": "note", "data": "Severe (assess for oral step down after 48 hours)"}, {"type": "order", "data": "ceFAZolin", "value": ""}, {"type": "sentence", "data": "2 g, IV Piggyback, Injection, q8hr(sched)"}, {"type": "note", "data": "<FONT style=&quot;BACKGROUND-COLOR: #80ff80&quot;>Purulent cellulitis</FONT>"}, {"type": "note", "data": "<FONT style=&quot;BACKGROUND-COLOR: #ffff80&quot;>Usually caused by S. aureus, including MRSA</FONT>"}, {"type": "note", "data": "For severe, non-responsive infections, consult Infectious Disease Specialist"}, {"type": "note", "data": "When abcesses/carbuncles/large furuncles are present, incision and drainage is the primary treatment (with antibiotics as adjuncts) "}, {"type": "note", "data": "Mild or moderate"}, {"type": "note", "data": "<FONT style=&quot;BACKGROUND-COLOR: #ffff80&quot;>Select cloxacillin OR cephalexin</FONT>"}, {"type": "order", "data": "cloxacillin", "value": ""}, {"type": "sentence", "data": "500 mg, PO, Cap, QID(empty stomach), 5 day(s)"}, {"type": "sentence", "data": "1,000 mg, PO, Cap, QID(empty stomach), 5 day(s)"}, {"type": "order", "data": "cephalexin", "value": ""}, {"type": "sentence", "data": "500 mg, PO, Tab, QID, 5 day(s)"}, {"type": "sentence", "data": "1,000 mg, PO, Tab, QID, 5 day(s)"}, {"type": "note", "data": "If MRSA history, ADD sulfamethoxazole-trimethoprim OR doxycycline"}, {"type": "note", "data": "Avoid&nbsp; sulfamethoxazole-trimethoprim in patients with eGFR less than 10 mL/min"}, {"type": "order", "data": "sulfamethoxazole-trimethoprim 800 mg-160 mg oral tablet", "value": ""}, {"type": "sentence", "data": "2 tabs, PO, Tab, BID, 5 day(s)"}, {"type": "sentence", "data": "1 tabs, PO, Tab, BID, 5 day(s)"}, {"type": "order", "data": "doxycycline", "value": ""}, {"type": "sentence", "data": "100 mg, PO, Cap, BID, 5 day(s)"}, {"type": "category", "data": "Laboratory"}, {"type": "order", "data": "CBC w/ Diff", "value": ""}, {"type": "sentence", "data": "Blood, Early AM collect, T+1;0630, Daily for 3 day(s)"}, {"type": "order", "data": "Urea", "value": ""}, {"type": "sentence", "data": "Blood, Early AM collect, T+1;0630, Daily for 3 day(s)"}, {"type": "order", "data": "Creatinine", "value": ""}, {"type": "sentence", "data": "Blood, Early AM collect, T+1;0630, Daily for 3 day(s)"}, {"type": "order", "data": "HgbA1C", "value": ""}, {"type": "sentence", "data": "Whole blood, Early AM collect, T+1;0630, Once"}, {"type": "note", "data": "Avoid intact skin and clean ulcer swabs "}, {"type": "note", "data": "For those who have abscesses and other purulent skin and soft-tissue infections, culture lesions "}, {"type": "note", "data": "Blood cultures should be done in all patients who are febrile/systemic symptoms or have neutropenia, severe cell-mediated immunodeficiency, malignancy on chemotherapy "}, {"type": "order", "data": "Wound Culture", "value": ""}, {"type": "sentence", "data": "Wound, Routine collect, T;N"}, {"type": "category", "data": "Consults/Referrals"}, {"type": "order", "data": "Consult to Physician", "value": ""}, {"type": "sentence", "data": "Infectious Disease"}, {"type": "order", "data": "Consult to Enterostomal Therapist", "value": ""}, {"type": "sentence", "data": "T;N, Cellulitis Skin and Soft"}]
